Clinical Trials on Malignant Lung Neoplasm

Total 149917 results

National Institute of Cancerología

Unknown

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Mexico
Zhongnan Hospital

Recruiting

Integrin αvβ6-targeted PET in Malignant Tumors

Malignant Neoplasm | PET/CT | Integrin αvβ6

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors

Neoplasm Malignant | Tumor, Solid | Cancer, Metastatic

China
Ohio State University Comprehensive Cancer Center

Completed

Checklist Tool in Engaging Patients in the Discharge Planning Process (TEPID)

Hospitalization | Malignant Neoplasm | Transitional Care Planning

United States
Delcath Systems Inc.

Unknown

Registry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic Malignancy

Hepatic Malignant Neoplasm Primary Non-Resectable

United Kingdom
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

Lung Cancer | Metastatic Cancer | Malignant Mesothelioma

United States
BioSyngen Pte Ltd

Unknown

A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites

Malignant Ascites | Malignant Pleural Effusion

Australia
Radboud University Medical Center

Terminated

Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion

Malignant Ascites | Malignant Pleural Effusion

Netherlands
Virttu Biologics Limited

Completed

Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma. (1716-12)

Malignant Pleural Mesothelioma

United Kingdom
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)

Recruiting

Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy

Malignant Solid Neoplasm | Hematopoietic and Lymphatic System Neoplasm

United States
Children's Oncology Group

Not yet recruiting

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

Malignant Solid Neoplasm | Hematopoietic and Lymphatic System Neoplasm
OHSU Knight Cancer Institute
Oregon Health and Science University; National Center for Complementary and...

Recruiting

Examining Arts as Therapy in Children With Cancer, CREATe Trial

Malignant Solid Neoplasm | Hematopoietic and Lymphatic System Neoplasm

United States
NRG Oncology
National Cancer Institute (NCI)

Not yet recruiting

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm
Mayo Clinic

Recruiting

Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm

United States
Roswell Park Cancer Institute

Recruiting

Community-Based Physical Activity Intervention for Underserved Cancer Survivors

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm

United States
Roswell Park Cancer Institute

Recruiting

Financial Health Educational Program for Increasing Financial Literacy Among Underserved Communities in Western New York

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm

United States
Ohio State University Comprehensive Cancer Center

Not yet recruiting

Online Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm

United States
Douglas Johnson
Incyte Corporation

Recruiting

Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Vincristine Pharmacokinetics in Infants

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States, Australia, Canada
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
M.D. Anderson Cancer Center

Recruiting

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; American...

Recruiting

Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm

United States
M.D. Anderson Cancer Center

Recruiting

Collection of Outcomes Data for Pregnant Patients With Cancer

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Thomas Jefferson University

Withdrawn

Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer Survivors (MiVSEEV)

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Mayo Clinic

Completed

Patient Registry in Patients Undergoing Contrast-Enhanced Harmonic Endoscopic Ultrasound Imaging

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm
Cancer Research UK
Royal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of Birmingham

Recruiting

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. (DETERMINE)

Glioma | Melanoma | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Neoplasms by Site | Cancer | Brain Neoplasms | Solid Tumor | Malignant Neoplasm | Malignancy | Haematological Malignancy

United Kingdom
Sunnybrook Health Sciences Centre
Genomic Health®, Inc.

Completed

The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population

Hormone Receptor Positive Malignant Neoplasm of Breast

Canada
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

Malignant Brain Neoplasm | Recurrent Malignant Brain Neoplasm | Refractory Malignant Brain Neoplasm

United States
David Bartlett
National Cancer Institute (NCI)

Completed

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

Peritoneal Carcinomatosis | Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface | Malignant Peritoneal Mesothelioma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); National Institute of Nursing Research (NINR) and other collaborators

Active, not recruiting

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

Delirium | Metastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Locally Advanced Malignant Neoplasm

United States
National Cancer Institute (NCI)

Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Malignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System Neoplasm

United States
National Cancer Institute (NCI)

Terminated

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Carcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Lung Cancer | Carcinoma, Esophageal | Malignant Pleural Mesotheliomas

United States
Tianhong Li
National Cancer Institute (NCI); LabyRx Immunologic Therapeutics

Recruiting

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Adenocarcinoma | Advanced Adenocarcinoma | Recurrent Adenocarcinoma

United States
Bristol-Myers Squibb

Recruiting

A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)

Mesothelioma, Malignant

Japan
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

Malignant Mesothelioma | CD30-Positive Neoplastic Cells Present

United States
Armando Santoro, MD

Completed

Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients

Malignant Mesothelioma

Italy
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

Malignant Mesothelioma

United States
Jonsson Comprehensive Cancer Center

Terminated

Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma

Pleural Epithelioid Mesothelioma | Pleural Malignant Mesothelioma

United States
University of Zurich

Completed

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Switzerland
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Terminated

Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107

Malignant Mesothelioma
University of Pennsylvania

Completed

Autologous Redirected RNA Meso-CIR T Cells

Malignant Pleural Mesothelioma

United States
Herbert Irving Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Malignant Mesothelioma

United States
Alfacell

Unknown

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Malignant Mesothelioma

United States, Poland, Italy, Germany
British Thoracic Society
Medical Research Council

Unknown

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

Malignant Mesothelioma

United Kingdom
European Organisation for Research and Treatment...

Completed

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

Malignant Mesothelioma

Canada, France, Switzerland, Belgium, Netherlands, Italy, United Kingdom, Egypt, Germany, Peru, Poland
European Organisation for Research and Treatment...

Completed

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

Malignant Mesothelioma

Italy, Netherlands

Clinical Trials on Malignant Lung Neoplasm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations